Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/01/2026 ,inter alia, to consider and approve the Un-audited Financial ....
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Suven Life Sciences has informed the stock exchanges that its Board of Directors will meet on January 29, 2026, at its registered office in Hyderabad. The main agenda is to consider and approve the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company also confirmed that the trading window for designated persons and their relatives has been closed since January 1, 2026 and will reopen 48 hours after the results are declared. This is a standard regulatory filing under SEBI's Listing Obligations and Disclosure Requirements.
This is a routine procedural announcement with no new financial information. Shareholders should watch for the actual Q3 results on January 29, 2026, which could move the stock depending on performance versus expectations. The closed trading window signals that insider trading restrictions are in place ahead of the results.